Managing Insomnia in the Primary Care Setting: Moving Towards Safer Therapies

Managing Insomnia in the Primary Care Setting: Moving Towards Safer Therapies is organized by Rockpointe Corporation.

Release Date: January 9, 2020
Expiration Date: January 9, 2021

Accreditation:
Physician Credit Designation
Boston University School of Medicine designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Designation Statement
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Nursing Credit Designation
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hours. Designated for 0.5 contact hours of pharmacotherapy credit for Advanced Practice Registered Nurses.

Overview:
Insomnia is an underrecognized, undertreated, and, unfortunately, often mistreated condition, putting patients at serious health risks that are preventable with evidence-based care. For patients who do not adequately respond to cognitive behavioral therapy for insomnia, multiple pharmacologic options are available that can be tailored to specific insomnia symptoms, and newer agents have improved safety profiles over conventional hypnotics. It is vital that clinicians are able to differentiate these agents based on patient symptoms to make optimal treatment selections to meet the needs of each individual patient.

The educational program, "Managing Insomnia in the Primary Care Setting: Moving Towards Safer Therapies," will reinforce the impact of insomnia on patient health, review related comorbidities, examine current and emerging therapies, and provide strategies for engaging patients in their insomnia management using a shared decision-making approach.

Educational Objectives:
This program is designed to address ACGME and NAM competencies, including delivering patient-centered care and practicing evidence-based medicine.
At the conclusion of this activity, participants should be able to:
• Identify the health risks and other factors associated with insomnia that indicate the need for timely and adequate assessment
• Implement personalized treatment plans for patients with insomnia based on current evidence
• Assess current clinical data on pharmacotherapies in development for insomnia
• Develop strategies for shared decision-making with patients regarding the management of their insomnia